AMO Pharma Announces Completion of Treatment of Last Patient in Pivotal REACH-CDM Clinical Trial in Myotonic Dystrophy.
In: PR Newswire, 2023-04-25
Zeitungsartikel
Zugriff:
Titel: |
AMO Pharma Announces Completion of Treatment of Last Patient in Pivotal REACH-CDM Clinical Trial in Myotonic Dystrophy.
|
---|---|
Zeitschrift: | PR Newswire, 2023-04-25 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|